Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pablo Romero
Observed names:
P. Romero-Gonzalez,
Pablo Romero-Gonzalez
Institutions:
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Universidad Autónoma de Madrid
Observed institutions:
The Francis Crick Institute,
Hospital Universitario Fundación Jiménez Díaz,
Instituto de Investigación Sanitaria Fundación Jiménez Díaz,
Hospital Universitario General de Villalba,
Universidad Autónoma de Madrid
ORCID:
0009-0000-7564-4028
Observed ORCID:
0009-0000-7564-4028
OpenAlex ID:
A5101624168
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A
2023
·
Javier Martin-Broto
, Jeronimo Martinez-Garcia
, et al.
·
Signal Transduction and Targeted Therapy
·
51
PDF
HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study
2024
·
David S. Moura
, Jose L. Mondaza-Hernandez
, et al.
·
Cellular and Molecular Life Sciences
·
8
PDF
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma
2024
·
José L. Mondaza-Hernandez
, Nadia Hindi
, et al.
·
Therapeutic Advances in Medical Oncology
·
2
Alternative splicing (AS) regulation as a novel therapeutic target in soft-tissue sarcoma (STS).
2023
·
David Silva Moura
, Esther Martinez-Font
, et al.
·
Journal of Clinical Oncology
·
1
Plasma ISG15 as predictor of outcome from antiangiogenic therapy in solitary fibrous tumor: Analysis from the GEIS-69 trial.
2026
·
Jose Lucinio Mondaza-Hernandez
, David Silva Moura
, et al.
·
Journal of Clinical Oncology
Prognostic significance of HMGB1 expression as a biomarker of immunogenic cell death in patients with leiomyosarcoma and undifferentiated pleomorphic sarcoma treated with chemo-immuno–based regimens.
2026
·
David Silva Moura
, Jose Lucinio Mondaza-Hernandez
, et al.
·
Journal of Clinical Oncology
PDF
84P Exploring BET inhibitors as promising agents for solitary fibrous tumor
2025
·
J.L. Mondaza-Hernandez
, Y. Li
, et al.
·
ESMO Open
PDF
Shared germline genomic variants in two patients with double primary gastrointestinal stromal tumours (GISTs)
2024
·
David S Moura
, Daniel López López
, et al.
·
Journal of Medical Genetics
Abstract P026: Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer
2022
·
Jesse Boumelha
, Sophie de Carné
, et al.
·
Cancer Immunology Research
Production and characterisation of rationally optimised, anti-melanoma T-cell receptors: a step closer towards immunotherapeutic treatment for patients
2008
·
Melita Irving
, Maya C. André
, et al.
·
Infoscience (Ecole Polytechnique Fédérale de Lausanne)
Show more works
View as search
Works count:
10
Citation count:
62
H-index:
2
I10-index:
1
Year
Topic
Type